Targeting therapy for malignant brain tumors
Kochi, M.; Ushio, Y.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(6): 738-742
1994
ISSN/ISBN: 0385-0684 PMID: 8185328 Document Number: 429220
Document emailed within 1 workday
Related Documents
Juhl, H.; Czubayko, F.; Henne-Bruns, D. 1998: Ribozyme targeting as gene therapy method for treatment of malignant tumors Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 115: 1474-1477Tamiya, T.; Ohmoto, T.; Wei, M.X.; Breakfield, X.O.; Chiocca, E.A. 1994: Gene therapy for brain tumors: gene therapy for malignant brain tumors using prodrug-sensitivity genes (series 4) No Shinkei Geka. Neurological Surgery 22(12): 1099-1110
Kostron, H. 1987: Therapy of malignant brain tumors Wiener Klinische Wochenschrift 99(11): 366-369
Hirschberg, H.; Sørensen, D.R.; Angell-Petersen, E.; Peng, Q.; Tromberg, B.; Sun, C-Ho.; Spetalen, S.; Madsen, S. 2006: Repetitive photodynamic therapy of malignant brain tumors Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 25(1-2): 261-279
Nagai, M.; Arai, T. 1982: Interferon therapy for malignant brain tumors-present and future No Shinkei Geka. Neurological Surgery 10(5): 463-476
Marek, K. 1972: Trial of cytostatic therapy of malignant brain tumors in adults Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 110(1): 27-43
Rob, L.; Svoboda, B.; Robová, H.; Stankusová, H.; Cwiertka, K.; Neumannová, R.; Petera, J.; Koliba, P.; Kudela, M. 2004: Guideline for gynecological malignant tumors--primary complex therapy in operable stages of malignant tumors of uterus cervix Ceska Gynekologie 69(5): 376-383
Takagaki, M.; Ono, K.; Oda, Y.; Kikuchi, H.; Nemoto, H.; Iwamoto, S.; Cai, J.; Yamamoto, Y. 1996: Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors Cancer Research 56(9): 2017-2020
Bunyaratavej, K.; Siwanuwatn, R.; Chantra, K.; Khaoroptham, S. 2010: Duration of symptoms in brain tumors: influencing factors and its value in predicting malignant tumors Journal of the Medical Association of Thailand 93(8): 903-910
Von Gumppenberg, S.; Fink, U.; Lindner, H. 1978: Therapy of malignant bone tumors. Recommendations for the therapy of malignant primary and secondary bone tumors Fortschritte der Medizin 96(31): 1542-1549
Ushio, Y.; Mogami, H. 1987: Chemotherapy of malignant brain tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(12): 3227-3233
Schiffer, D.; Sales, S.; Soffietti, R. 1991: Lonidamine in malignant brain tumors Seminars in Oncology 18(2 Suppl 4: 38-41
Stieglmayr, F.S. 1973: Chemotherapy of malignant brain tumors Wiener Medizinische Wochenschrift 123(44): 637-642
Matsutani, M. 1997: Chemoradiation for malignant brain tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(14): 2042-2048
Ransohoff, J. 1977: Surgical management of malignant brain tumors National Cancer Institute Monograph 46: 145-150
Eary, J.F.; Mankoff, D.A.; Spence, A.M.; Berger, M.S.; Olshen, A.; Link, J.M.; O'Sullivan, F.; Krohn, K.A. 1999: 2-[C-11]thymidine imaging of malignant brain tumors Cancer Research 59(3): 615-621
Takeshima, H.; Kuratsu, J.-i. 2003: Evolution of chemotherapy for malignant brain tumors No Shinkei Geka. Neurological Surgery 31(7): 725-734
Lanksch, W.; Stochdorph, O. 1972: Which brain tumors are histologically and which are topographically malignant? Zeitschrift für Allgemeinmedizin 48(22): 1009-1012
Knerich, R.; Butti, G.; Pezzotta, S.; Robustelli della Cuna, G.; Adinolfi, D.; Pavesi, L. 1984: Chemotherapy of malignant brain tumors in childhood Minerva Medica 75(24): 1441-1444
Harik, S.I.; Sutton, C.H. 1979: Putrescine as a biochemical marker of malignant brain tumors Cancer Research 39(12): 5010-5015